Serina Therapeutics, Inc. (SER) is a publicly traded Healthcare sector company. As of May 21, 2026, SER trades at $1.71 with a market cap of $22.65M and a P/E ratio of -0.90. SER moved +5.59% today. Year to date, SER is -18.27%; over the trailing twelve months it is -70.23%. Its 52-week range spans $1.22 to $8.14. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces SER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Serina Therapeutics, Inc. (SER) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SER moved +5.59% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.71 |
| Market Cap | $22.65M |
| P/E Ratio | -0.90 |
| EPS | $-1.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.14 |
| 52-Week Low | $1.22 |
| Volume | 115.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $130.00K |
| Net Income | $-19.21M |
| Gross Margin | 0.00% |
1 analysts cover SER: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.